Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations

By Ward K. W.   Azzarano L. M.   Evans C. A.   Smith B. R.  

Xenobiotica, Vol. 34, Iss. 4, 2004-04 ,pp. : 353-366

Informa Healthcare

Access to resources Recommend Favorite

Transporter-mediated uptake into cellular compartments

By Oswald S.   Grube M.   Siegmund W.   Kroemer H. K.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1171-1195

Informa Healthcare

Access to resources Recommend Favorite

The Novel Neuropeptide Y Y₁ Receptor Antagonist J-104870: A Potent Feeding Suppressant with Oral Bioavailability

By Kanatani A.   Kanno T.   Ishihara A.   Hata M.   Sakuraba A.   Tanaka T.   Tsuchiya Y.   Mase T.   Fukuroda T.   Fukami T.   Ihara M.  

Biochemical and Biophysical Research Communications, Vol. 266, Iss. 1, 1999-12 ,pp. : 88-91

Elsevier

Access to resources Recommend Favorite

Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates

By Umehara K. -I.   Iwatsubo T.   Noguchi K.   Kamimura H.  

Xenobiotica, Vol. 37, Iss. 6, 2007-06 ,pp. : 618-634

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase

By Austin N. E.   Baldwin S. J.   Cutler L.   Deeks N.   Kelly P. J.   Nash M.   Shardlow C. E.   Stemp G.   Thewlis K.   Ayrton A.   Jeffrey P.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite